secwatch.observer — SEC 8-K summary
======================================

Issuer:     TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
CIK:        0000818686
Form:       8-K
Filed at:   2026-05-28T20:05:43+00:00
Accession:  0001193125-26-245203
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Teva shareholders re-elect Sol J. Barer to board, approve advisory pay vote
---------------------------------------------------------------------------

- Dr. Sol J. Barer elected to board with 627.8M for, 245.9M against, 0.5M abstain (broker non-votes 50.7M).
- Non-binding advisory compensation proposal passed with 796.0M for, 77.1M against, 1.2M abstain.
- Kesselman & Kesselman (PwC) ratified as independent auditor for 2027 with 880.5M for, 36.1M against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/818686/000119312526245203/0001193125-26-245203-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/818686/000119312526245203/d342755d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-245203

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer